Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better?

Launched by CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS · Dec 1, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at two methods for collecting urine samples to detect bladder cancer. The study compares using a flexible tube called a cystoscope, which is inserted into the bladder, to a more traditional method using a larger catheter after the cystoscope is removed. Researchers want to see if the cystoscope method is just as effective but less uncomfortable for patients. If the trial shows that the cystoscope method works well, it could lead to simpler and more comfortable procedures for bladder cancer testing in the future.

To participate in this study, men aged 18 and older who are scheduled for a flexible cystoscopy and urinary cytology may be eligible. Participants will need to be able to understand and sign an informed consent form and should speak French. It’s important to note that individuals who have had certain urinary procedures recently or cannot give informed consent will not be included in the study. Participants can expect to undergo a standard cystoscopy procedure, and their experiences will help improve bladder cancer testing for everyone.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Men aged \> or = 18 years
• • 2. Patients scheduled for a flexible cystoscopy and urinary cytology.
• • 3. Patients who have signed the informed consent.
• • 4. Patients who speak French
• Exclusion Criteria:
• • 1. Manipulations or instrumentation of urinary tract, including but not limited to Double-J stent placement or removal, and/or bladder biopsy
• • 2. Inability to give informed consent or without capacity of discernment